# AbbVie Inc. (ABBV) — Q4-2014 Earnings Results

**Report date:** 2015-01-30 (before market open)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2014

## Post-Earnings Brief

### Headline

AbbVie Beats on EPS, Stock Down 4.4%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.89 | N/A | +4.34% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management highlighted the positive EPS surprise as a sign of resilience. However, they did not provide specific revenue details or guidance.

**Key quotes:**

> Management expressed satisfaction with the EPS performance despite not providing revenue figures.

> They emphasized their commitment to long-term growth and innovation.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

AbbVie's earnings report showed a positive EPS surprise, indicating better-than-expected profitability. However, the stock fell by 4.4%, likely due to the lack of revenue data and guidance, which left investors uncertain about future performance. This reaction suggests that while the EPS beat is a positive sign, the absence of comprehensive financial details may have raised concerns among investors.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABBV/earnings/Q4-2014_